Effect of creatine supplementation on metabolite levels in ALS motor cortices

被引:40
作者
Vielhaber, S
Kaufmann, J
Kanowski, M
Sailer, M
Feistner, H
Tempelmann, C
Elger, CE
Heinze, HJ
Kunz, WS
机构
[1] Univ Magdeburg, Med Ctr, Dept Neurol 2, D-39120 Magdeburg, Germany
[2] Univ Bonn, Ctr Med, Dept Epileptol, D-53105 Bonn, Germany
关键词
amyotrophic lateral sclerosis; N-acetylaspartate; magnetic resonance spectroscopy; creatine; mitochondria;
D O I
10.1006/exnr.2001.7797
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mitochondrial pathology is an early observation in motor neurons and skeletal muscle of patients with amyotrophic lateral sclerosis (ALS). To clarify the relevance of this finding, we determined the effects of a I-month oral administration of creatine on H-1 NMR-visible metabolites in the motor cortices of 15 controls and 15 patients with sporadic ALS, most of whom had mitochondrial pathology in skeletal muscle. In the motor cortex of the ALS group the N-acetylaspartate (NAA)/ creatine (Cr-t) metabolite ratio was lower than in our control group, indicating NAA loss. Upon creatine supplementation we observed in the controls a decline in the NAA/Cr-t, NAA/choline (Cho), glutamate + glutamine (Glx)/Cr-t, and Glx/Cho metabolite ratios. In contrast, in the ALS patient group the NAA/Cr-t and the NAA/Cho metabolite ratios remained unchanged, while the Glx/Cr-t and Glx/Cho metabolite ratios decreased. These data are compatible with the interpretation that creatine supplementation causes an increase in the diminished NAA levels in ALS motor cortex as well as an increase of choline levels in both ALS and control motor cortices. Because NAA is synthesized by mitochondria in an energy-dependent manner and the NAA/Cho metabolite ratios in the ALS motor cortices were found to be correlated to the degree of mitochondrial pathology in ALS skeletal muscle, our results can be explained by a deficiency of enzymes of mitochondrial respiratory chain in the ALS motor cortex which might affect motor neuron Survival. (C) 2001 Elsevier Science.
引用
收藏
页码:377 / 382
页数:6
相关论文
共 24 条
[1]   Inhibition of N-acetylaspartate production: Implications for H-1 MRS studies in vivo [J].
Bates, TE ;
Strangward, M ;
Keelan, J ;
Davey, GP ;
Munro, PMG ;
Clark, JB .
NEUROREPORT, 1996, 7 (08) :1397-1400
[2]   Mitochondria and the pathogenesis of ALS [J].
Beal, MF .
BRAIN, 2000, 123 :1291-1292
[3]   Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease -: Subgroup analysis and follow-up measurements [J].
Block, W ;
Karitzky, J ;
Träber, F ;
Pohl, C ;
Keller, E ;
Mundegar, RR ;
Lamerichs, R ;
Rink, H ;
Ries, F ;
Schild, HH ;
Jerusalem, F .
ARCHIVES OF NEUROLOGY, 1998, 55 (07) :931-936
[4]  
Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO
[5]  
2-8
[7]   N-acetyl aspartate:: A marker for neuronal loss or mitochondrial dysfunction [J].
Clark, JB .
DEVELOPMENTAL NEUROSCIENCE, 1998, 20 (4-5) :271-276
[8]   Increase of total creatine in human brain after oral supplementation of creatine-monohydrate [J].
Dechent, P ;
Pouwels, PJW ;
Wilken, B ;
Hanefeld, F ;
Frahm, J .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1999, 277 (03) :R698-R704
[9]   Mitochondrial DNA deletion mutation levels are elevated in ALS brains [J].
Dhaliwal, GK ;
Grewal, RP .
NEUROREPORT, 2000, 11 (11) :2507-2509
[10]   ASSAY CONDITIONS FOR THE MITOCHONDRIAL NADH - COENZYME-Q OXIDOREDUCTASE [J].
ESTORNELL, E ;
FATO, R ;
PALLOTTI, F ;
LENAZ, G .
FEBS LETTERS, 1993, 332 (1-2) :127-131